Uncontrolled plasma proteolysis: a major threat to the septicemic patient.

[1]  Aasen Ao.  The proenzyme functional inhibition index. A new parameter for evaluation of the severely injured and septic patient. , 1985 .

[2]  A. Aasen,et al.  Evaluation of severity and prognosis in early stages of septicemia by means of chromogenic peptide substrate assays. , 1984, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes.

[3]  O. Rekvig,et al.  Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. , 1984, British medical journal.

[4]  Å. Lasson.  Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment. , 1984, Scandinavian Journal of Gastroenterology, Supplement.

[5]  J. Verhoef,et al.  Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus. , 1983, The Journal of infectious diseases.

[6]  A. Aasen,et al.  The functional inhibition of plasma kallikrein. A critical factor in septic shock. , 1983, Advances in Experimental Medicine and Biology.

[7]  H. Büller,et al.  Postoperative hemostatic profile in relation to gram‐negative septicemia , 1982, Critical Care Medicine.

[8]  T. Jw.  Antithrombin-III: clinical significance. , 1982, Acta chirurgica Scandinavica. Supplementum.

[9]  R. Mcconn.  The role of chemical mediators in the pathophysiology of acute illness and injury , 1982 .

[10]  A. Aasen,et al.  Methodological considerations on chromogenic peptide substrate assays and application on automated analyzers. , 1982, Acta chirurgica Scandinavica. Supplementum.

[11]  A. Aasen,et al.  Studies of components of the coagulation systems in normal individuals and septic shock patients. , 1982, Circulatory shock.

[12]  A. Aasen,et al.  Treatment of sepsis in the surgical patient evaluated by means of chromogenic peptide substrate assays. , 1982, Acta chirurgica Scandinavica. Supplementum.

[13]  P. Friberger.  Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems. , 1982, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[14]  J. T. ten Cate,et al.  Quantitative Endotoxin Determination In Blood With A Chromogenic Substrate , 1981, Thrombosis and Haemostasis.

[15]  J. T. ten Cate,et al.  Antithrombin III deficiency in surgical intensive care patients. , 1981, Thrombosis Research.

[16]  M. Scully,et al.  Evaluation of a chromogenic method for endotoxin measurement. , 1980, Thrombosis research.

[17]  P. V. D. van der Starre,et al.  Inhibition of the hypotensive effect of plasma protein solutions by C1 esterase inhibitor. , 1980, Journal of Thoracic and Cardiovascular Surgery.

[18]  D. Evered,et al.  Protein degradation in health and disease. , 1980 .

[19]  A. Aasen,et al.  Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock. , 1980, Advances in shock research.

[20]  Gottfried El.  Plasmapheresis for meningococcemia with disseminated intravascular coagulation. , 1979 .

[21]  G. Claeson,et al.  Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. , 1979, Advances in experimental medicine and biology.

[22]  H. Fritz.  Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia): biochemical, pathophysiological and therapeutic aspects. , 1979, Ciba Foundation symposium.

[23]  A. Aasen,et al.  Activation of human plasma prekallikrein: influence of activators, activation time and temperature and inhibitors. , 1978, Thrombosis research.

[24]  H. Schipper,et al.  ANTITHROMBIN-III TRANSFUSION IN DISSEMINATED INTRAVASCULAR COAGULATION , 1978, The Lancet.

[25]  C. Kluft.  Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein. , 1978, The Journal of laboratory and clinical medicine.

[26]  G. Claeson,et al.  Methods for the Determination of Plasmin, Antiplasmin and Plasminogen by Means of the Substrate S-2251 , 1977, Thrombosis and Haemostasis.

[27]  G. Claeson,et al.  A new sensitive and highly specific chromogenic peptide substrate for factor Xa. , 1977, Thrombosis research.

[28]  R. Colman,et al.  Kinin activation in the blood of patients with sepsis. , 1976, Surgery, gynecology & obstetrics.

[29]  O. Odegård,et al.  Heparin cofactor activity measured with an amidolytic method. , 1975, Thrombosis research.

[30]  M. Blombäck,et al.  The assay of antithrombin using a synthetic chromogenic substrate for thrombin. , 1974, Thrombosis Research.

[31]  E. Hirsch,et al.  Kinin system responses in sepsis after trauma in man. , 1974, The Journal of surgical research.

[32]  M. Blombäck,et al.  Determination of plasma prothrombin with a reaction rate analyzer using a synthetic substrate. , 1974, Thrombosis Research.

[33]  W. R. Mccabe.  Serum complement levels in bacteremia due to gram-negative organisms. , 1973, The New England journal of medicine.

[34]  M. Blombäck,et al.  Substrates for determination of trypsin, thrombin and thrombin-like enzymes. , 1972, Folia haematologica.

[35]  R. Colman,et al.  Plasma kallikrein and Hageman factor in Gram-negative bacteremia. , 1970, Annals of internal medicine.

[36]  D. Tatter,et al.  PSEUDOMONAS SEPTICEMIA WITH INTRAVASCULAR CLOTTING LEADING TO THE GENERALIZED SHWARTZMAN REACTION. , 1964, The New England journal of medicine.